Correlation between C-reactive Protein Levels with Cognitive Function and Body Mass Index in Schizophrenia
DOI:
https://doi.org/10.3889/oamjms.2021.6305Keywords:
C-reactive protein, Cognitive function, Body mass index, SchizophreniaAbstract
AIM: The objectives of the study were to determine the correlation between C-reactive protein (CRP) levels with cognitive function and body mass index (BMI) in a patient with schizophrenia.
METHODS: This is a numerical correlative analytic study with a cross-sectional approach by means of nonprobability sampling with consecutive sampling with inclusion and exclusion criteria from August 2019 to November 2019 in the Prof. Dr. M. Ildrem Psychiatric Hospital in Province of North Sumatra after getting approval from the Research Ethics Committee at the Faculty of Medicine, University of North Sumatra.
RESULTS: There is a very strong correlation in which Pearson correlation test between the high-sensitivity CRP (HsCRP) value with BMI and the Montreal cognitive assessment Versi Indonesia score in schizophrenic patients with a correlation coefficient value of r = 0.951 and r = –0.743, respectively, with a very strong correlation (p < 0.001).
CONCLUSIONS: Increased pro-inflammatory activity, especially HsCRP may cause impaired cognitive function in people with schizophrenia.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Tamminga CA. Introduction and Overview. In: Sadock VA, Kaplan RP, Sadock BJ, editor. Comprehensive Texbook of Psychiatry. 9th ed. New York: Lippincott Williams and Wilkins; 2009. p. 1433-7.
Sadock BJ, Sadock VA. Introduction and overview. In: Kaplan and Sadock’s Synopsis of Psychiatry Behavioral Sciences/Clinical Psychiatry. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007. p. 468-97. https://doi.org/10.1097/00004850-198907000-00008 DOI: https://doi.org/10.1097/00004850-198907000-00008
Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, et al. C-Reactive protein is allevated in schizophrenia. Schizophr Res. 2013;143(1):198-202. https://doi.org/10.1016/j.schres.2012.10.041 PMid:23218564 DOI: https://doi.org/10.1016/j.schres.2012.10.041
Singh S, Chaudhuri KT. Role of C-reactive protein in schizophrenia: An overview. Psychiatry Res. 2014;216(2):277-85. PMid:24565000 DOI: https://doi.org/10.1016/j.psychres.2014.02.004
Fan X, Golf DC, Henderson DC. Inflammation and schizophrenia. Expert Rev Neurother. 2007;7(7):789-96. PMid:17610386 DOI: https://doi.org/10.1586/14737175.7.7.789
Dimitrov HD, Braida N, Bass WC. The Link between Immune System Dysregulation and Schizophrenia; 2001. Available from: http://www.psichiatryctimes.com. [Last accessed on 06 Aug 2020].
Akanji OA, Ohaeri JU, Al-Shammri S, Fatania HR. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenia patiens. Psychiatry Res. 2009;169(1):56-61. https://doi.org/10.1016/j.psychres.2008.06.010 PMid:19619902 DOI: https://doi.org/10.1016/j.psychres.2008.06.010
Diyanoosh N, Rezaei O, Masafi S, Nazeri A, Hoseynzade. Relationship of blood C-reactive protein (crp) level and cognitive deficit in patien with schizophrenia. Int J Res Intern Med Puclic Health. 2012;4:1785-92.
Newcomer JW, Fahnestock PA, Haupt DW. Medical health in schizophrenia. In: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. 9th ed., Vol. 1. Philadelphia, PA: Lippincot Williams and Wilkins; 2009. p. 1576-7.
Norlelawati AT, Kartini A, Ramli M, Norsidah K, Azizi WW, Tariq AR. Obesity in multiracial schizophrenia patients receiving outpatient treatment in a regional tertiary hospital in Malaysia. East Asian Arch Psychiatry. 2012;22(2):49-56. https://doi.org/10.1111/appy.12089 PMid:22714874 DOI: https://doi.org/10.1111/appy.12089
Fond G, Godin O, Llorca PM, Leboyer M. Abnormal C-reactive protein (CRP) levels in schizophrenia and schizoaffective disorders. Results from the FACE-SZ dataset. Eur Psychiatry. 2015;30S:S102-61. https://doi.org/10.1016/j.eurpsy.2015.09.213 DOI: https://doi.org/10.1016/j.eurpsy.2015.09.213
Boozalis T, Devaraj S, Okusaga OO. Correlations between body mass index, plasma high-sensitivity c-reactive protein and lipids in patients with schizophrenia. Psychiatr Q. 2019;90(1):101-10. https://doi.org/10.1007/s11126-018-9606-3 PMid:30315442 DOI: https://doi.org/10.1007/s11126-018-9606-3
Joseph J, Depp C, Martin AS, Daly RE, Glorioso DK, Palmer BW, et al. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res. 2015;168(1-2):456-60. https://doi.org/10.1016/j.schres.2015.08.019 PMid:26341579 DOI: https://doi.org/10.1016/j.schres.2015.08.019
Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia. Schizophr Res. 2007;89(1-3):173-6. https://doi.org/10.1016/j.schres.2006.08.015 PMid:17029750 DOI: https://doi.org/10.1016/j.schres.2006.08.015
Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 2003;60(5):466-72. https://doi.org/10.1001/archpsyc.60.5.466 PMid:12742867 DOI: https://doi.org/10.1001/archpsyc.60.5.466
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Putra M. Mahmuddin, Elmeida Efffendy, Mustafa M. Amin (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
